Literature DB >> 167947

Clonal isolation of epithelial cells from mouse lung adenoma.

G D Stoner, Y Kikkawa, A J Kniazeff, K Miyai, R M Wagner.   

Abstract

Clones of epithelial-like cells were established from urethan-induced mouse lung adenoma. Electron microscopy of one clone showed that the cells contained lamellar inclusion bodies similar in appearance to those seen in the adenoma precursor, the type II alveolar pneumocyte. The clones exhibited characteristics associated with both "transformed" and "normal" cells in culture; i.e., although aneuploid, the cells grew at a slower rate than most transformed cells, did not form colonies in soft agar and, after prolonged subculture, were not tumorigenic when transplanted s.c. into appropriate hosts. Hydrocortisone treatment of the cloned cells led to growth stimulation and the eventual acquisition of neoplastic potential. Epithelial tumors were produced more readily in athymic, nude mice than in antilymphocyte serum-treated A/He mice. The cells are producing a C-type RNA virus into the culture medium.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 167947

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  20 in total

1.  Induction of necroptotic cell death by viral activation of the RIG-I or STING pathway.

Authors:  Suruchi N Schock; Neha V Chandra; Yuefang Sun; Takashi Irie; Yoshinori Kitagawa; Bin Gotoh; Laurent Coscoy; Astar Winoto
Journal:  Cell Death Differ       Date:  2017-01-06       Impact factor: 15.828

2.  A cell culture model of chemically and spontaneously derived mouse lung alveologenic carcinoma.

Authors:  G J Smith; J G Steele; J M Bentel; C K Loo
Journal:  Cell Biol Toxicol       Date:  1988-09       Impact factor: 6.691

3.  The phospholipids of rabbit type II alveolar epithelial cells: comparison with lung lavage, lung tissue, alveolar macrophages, and a human alveolar tumor cell line.

Authors:  S A Rooney; L L Nardone; D L Shapiro; E K Motoyama; L Gobran; N Zaehringer
Journal:  Lipids       Date:  1977-05       Impact factor: 1.880

4.  Contributions of E1A to mouse adenovirus type 1 pathogenesis following intranasal inoculation.

Authors:  Jason B Weinberg; Daniel R Jensen; Lisa E Gralinski; Amy R Lake; Gregory S Stempfle; Katherine R Spindler
Journal:  Virology       Date:  2006-09-07       Impact factor: 3.616

5.  Adaptation of an ICAM-1-tropic enterovirus to the mouse respiratory tract.

Authors:  Eric S Wang; Elena Dobrikova; Christian Goetz; Andrew T Dufresne; Matthias Gromeier
Journal:  J Virol       Date:  2011-03-30       Impact factor: 5.103

6.  Influenza A Virus Infection Induces Viral and Cellular Defective Ribosomal Products Encoded by Alternative Reading Frames.

Authors:  Damien J Zanker; Sara Oveissi; David C Tscharke; Mubing Duan; Siyuan Wan; Xiaomu Zhang; Kun Xiao; Nicole A Mifsud; James Gibbs; Lenny Izzard; Daniel Dlugolenski; Pierre Faou; Karen L Laurie; Nathalie Vigneron; Ian G Barr; John Stambas; Benoît J Van den Eynde; Jack R Bennink; Jonathan W Yewdell; Weisan Chen
Journal:  J Immunol       Date:  2019-05-15       Impact factor: 5.422

7.  Crocidolite induces prostaglandin I(2) release mediated by vitronectin receptor and cyclooxygenase-2 in lung cells.

Authors:  Francisco J Leyva; Kevan Roberts
Journal:  Lung       Date:  2010-02-13       Impact factor: 2.584

8.  Clara cell adenomas of the mouse lung. Interaction with alveolar type 2 cells.

Authors:  K C Palmer
Journal:  Am J Pathol       Date:  1985-09       Impact factor: 4.307

9.  Role for mitogen-activated protein kinase p38 alpha in lung epithelial branching morphogenesis.

Authors:  Yuru Liu; Lesly Martinez; Kazumi Ebine; Mark K Abe
Journal:  Dev Biol       Date:  2007-12-14       Impact factor: 3.582

10.  The Fas/FasL pathway impairs the alveolar fluid clearance in mouse lungs.

Authors:  Raquel Herrero; Mishie Tanino; Lincoln S Smith; Osamu Kajikawa; Venus A Wong; Steve Mongovin; Gustavo Matute-Bello; Thomas R Martin
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-06-28       Impact factor: 5.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.